Lawrence D. Mayer
Suite 250-887 Great Northern Way
Vancouver, BC, Canada
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Pharmacokinetics, drug metabolism, and tissue distribution of CPX-351 in animals.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: March 26, 2020
A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemias.
Journal: Cancer chemotherapy and pharmacology
Published: April 03, 2019
CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties.
Journal: International journal of nanomedicine
Published: October 12, 2018
CPX-351 exhibits hENT-independent uptake and can be potentiated by fludarabine in leukaemic cells lines and primary refractory AML.
Journal: Leukemia research
Published: March 08, 2018
Improving combination cancer therapy: the CombiPlex® development platform.
Journal: Future oncology (London, England)
Published: January 25, 2018
CPX-351 exhibits potent and direct ex vivo cytotoxicity against AML blasts with enhanced efficacy for cells harboring the FLT3-ITD mutation.
Journal: Leukemia research
Published: September 18, 2016
Passive and semi-active targeting of bone marrow and leukemia cells using anionic low cholesterol liposomes.
Journal: Journal of drug targeting
Published: May 05, 2016
Efficacy of CPX-351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program.
Journal: Pediatric blood & cancer
Published: March 19, 2014
Nanoscale particulate systems for multidrug delivery: towards improved combination chemotherapy.
Journal: Therapeutic delivery
Published: February 04, 2014
Cohort differences in dementia recognition and treatment indicators among assisted living residents in Maryland: did a change in the resident assessment tool make a difference?
Journal: International psychogeriatrics
Published: September 25, 2013
The impact of complex chronic diseases on care utilization among assisted living residents.
Journal: Geriatric nursing (New York, N.Y.)
Published: June 25, 2013
Prediction of nanoparticle prodrug metabolism by pharmacokinetic modeling of biliary excretion.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 09, 2013
Last Updated: 09/26/2026